SADS in Children - KQ3

Project Summary Title and Description

Title
SADS in Children - KQ3
Description
Screening for Anxiety Depression and Suicide Risk in Children and Adolescents - Key Questions 3 - Harms of Screening
Attribution
N/A
Authors of Report
Meera Viswanathan, PhD Ina Wallace, PhD Jennifer Cook Middleton, PhD Sara M. Kennedy, MPH Joni McKeeman, PhD Kesha Hudson, PhD Caroline Rains, MPH Emily B. Vander Schaaf, MD, MPH Leila Kahwati, MD, MPH
Methodology description
Systematic Review
PROSPERO
NA
DOI
doi: 10.1001/jama.2022.16303.
Notes
Background: Mental health conditions in children and adolescents may present as physical symptoms and may occur concurrently, presenting primary care physicians with opportunities to screen for one or more conditions. Purpose: To review the evidence on screening (benefits and harms of screening, accuracy of screening, benefits and harms of treatment) for suicide risk, anxiety, and depression in children and adolescents in settings relevant to primary care in the United States for the U.S. Preventive Services Task Force. Data Sources: PubMed, the Cochrane Library, PsycINFO, CINAHL and trial registries through July 19, 2021; bibliographies from retrieved articles, outside experts, and surveillance of the literature through June 1, 2022. Study Selection: Two investigators independently selected English-language studies using a priori defined criteria. We included trials that evaluated the benefits or harms of screening for suicide risk, anxiety, or depression compared with no screening or usual care. We included studies of screening with instruments feasible in primary care settings. For treatment benefits and harms, we included drugs approved for pediatric use by the Food and Drug Administration. For suicide and depression treatment studies, we included any eligible psychotherapy or collaborative care interventions. For anxiety, we restricted nonpharmacological interventions to cognitive behavioral therapy (CBT). Eligible outcomes included test accuracy, symptoms, response, remission, loss of diagnosis, all-cause mortality, functioning, suicide-related symptoms or events, withdrawal due to adverse events, serious adverse events, and harms from screening. We also included systematic reviews reporting on harms of treatment. We excluded studies with poor methodological quality. Data Extraction: One investigator extracted data and a second checked accuracy. Two reviewers independently rated methodological quality for all included studies. When at least three similar studies were available, we conducted meta-analyses. Link to full report: https://www.ncbi.nlm.nih.gov/books/NBK585407/
Funding Source
AHRQ Contract No. HHSA-290-2015-00011-I, Task Order No. 15

Key Questions

1. Imported User Info
2. Imported User Info
3. Imported User Info
4. Imported User Info
5. Imported User Info
6. Imported User Info
7. Imported User Info
8. Imported User Info
9. Imported User Info
10. Imported User Info
11. Imported User Info
12. Imported User Info
13. Imported User Info
14. Imported User Info
15. Imported User Info
16. Imported User Info
17. Imported User Info
18. Imported User Info
19. Imported User Info
20. Imported User Info
21. Imported User Info
22. Imported User Info
23. Imported User Info
24. Imported User Info
25. Imported User Info
26. Imported User Info
27. Imported User Info
28. Imported User Info
29. Imported User Info
30. Imported User Info
31. Imported User Info
32. Imported User Info
33. Imported User Info
34. Imported User Info
35. Imported User Info
36. Imported User Info
37. Imported User Info
38. Imported User Info
39. Imported User Info
40. Imported User Info
41. Imported User Info
42. Imported User Info
43. Imported User Info
44. Imported User Info
45. Imported User Info
46. Imported User Info
47. Imported User Info
48. Imported User Info
49. Imported User Info
50. Imported User Info
51. Imported User Info
52. Imported User Info
53. Imported User Info
54. Imported User Info
55. Imported User Info
56. Imported User Info
57. Key Question 3. What are the harms associated with screening for depression, anxiety, or suicide risk in primary care or comparable settings in children and adolescents?

Associated Extraction Forms

Type
Standard

Associated Studies (each link opens a new tab)

Title Authors Year
Does screening high school students for psychological distress, deliberate self-harm, or suicidal ideation cause distress--and is it acceptable? An Australian-based study Robinson, J., Pan Yuen, H., Martin, C., Hughes, A., Baksheev, G. N., Dodd, S., Bapat, S., Schwass, W., McGorry, P., Yung, A. R. 2011
Evaluating iatrogenic risk of youth suicide screening programs: a randomized controlled trial Gould, M. S., Marrocco, F. A., Kleinman, M., Thomas, J. G., Mostkoff, K., Cote, J., Davies, M. 2005

Downloadable Data Content

Files
  • XLSX Project Data